Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mainz Biomed (MYNZ) Non-Current Deferred Tax Liability (2022 - 2024)

Historic Non-Current Deferred Tax Liability for Mainz Biomed (MYNZ) over the last 3 years, with Q2 2024 value amounting to -$18196.0.

  • Mainz Biomed's Non-Current Deferred Tax Liability fell 126709.24% to -$18196.0 in Q2 2024 from the same period last year, while for Jun 2024 it was -$18196.0, marking a year-over-year decrease of 126709.24%. This contributed to the annual value of $138889.0 for FY2023, which is 3035.0% down from last year.
  • Per Mainz Biomed's latest filing, its Non-Current Deferred Tax Liability stood at -$18196.0 for Q2 2024, which was down 126709.24% from $138889.0 recorded in Q4 2023.
  • Mainz Biomed's Non-Current Deferred Tax Liability's 5-year high stood at $199410.0 during Q4 2022, with a 5-year trough of -$18196.0 in Q2 2024.
  • In the last 3 years, Mainz Biomed's Non-Current Deferred Tax Liability had a median value of -$1310.0 in 2023 and averaged $63492.4.
  • As far as peak fluctuations go, Mainz Biomed's Non-Current Deferred Tax Liability crashed by 3035.0% in 2023, and later crashed by 126709.24% in 2024.
  • Over the past 3 years, Mainz Biomed's Non-Current Deferred Tax Liability (Quarter) stood at $199410.0 in 2022, then plummeted by 30.35% to $138889.0 in 2023, then crashed by 113.1% to -$18196.0 in 2024.
  • Its Non-Current Deferred Tax Liability was -$18196.0 in Q2 2024, compared to $138889.0 in Q4 2023 and -$1331.0 in Q2 2023.